What Researchers Did
Researchers analyzed existing case series to understand bisphosphonate-associated osteonecrosis of the jaw (ONJ).
What They Found
The study found that ONJ appears to be associated with bisphosphonate use. Major risk factors identified include cancer (or chemotherapy for cancer) and dental procedures or oral trauma. The authors suggest that intensive hyperbaric oxygen therapy may be beneficial for patients with ONJ.
Canadian Relevance
No direct Canadian connection identified. This study was not conducted by Canadian authors or in Canada. While osteonecrosis of the jaw is a serious condition, bisphosphonate-associated ONJ is not specifically listed as a Health Canada-recognized indication for HBOT, distinct from osteoradionecrosis.
Study Limitations
The study notes that more investigation is needed to fully understand the disease's causes, how often it occurs, and related health issues, and to establish more definitive treatment guidelines.